3European Medicines Agency.Fifth pandemic pharmacovigilance weekly update[R].www.emea.europa.eu,6 January 2010. 被引量:1
4Medicine and Healthcare Products Regulatory Agency.Suspected Adverse Drug Reaction(ADR) Analysis:Swine Flu Vaccines-H1N1(Celvapan and Pandemrix)[R].www.mhra.gov.uk,5 March 2009. 被引量:1
5XiaoFeng Liang,HuaQing Wang,JunZhi Wang,et al.Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:a multicentre,double-blind,randomised,placebo-controlled trial[J].Lancet,2010,375(9708):56-66. 被引量:1
6FengCai Zhu,Hua Wang,HanHua Fang,et al.A Novel Influenza A (H1N1) Vaccine in Various Age Groups[J].N Engl J Med,2009,361(25):2414-2423. 被引量:1